Seelaus Asset Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,847
Closed -$420K 196
2023
Q4
$420K Buy
1,847
+500
+37% +$105K 0.41% 85
2023
Q3
$271K Sell
1,347
-4,120
-75% -$869K 0.31% 117
2023
Q2
$1.13M Buy
5,467
+3,354
+159% +$651K 0.89% 26
2023
Q1
$418K Buy
+2,113
New +$435K 0.32% 103
2022
Q1
Sell
-1,392
Closed -$376K 291
2021
Q4
$376K Sell
1,392
-1,036
-43% -$256K 0.2% 149
2021
Q3
$587K Hold
2,428
0.34% 88
2021
Q2
$575K Sell
2,428
-1,507
-38% -$343K 0.34% 96
2021
Q1
$862K Sell
3,935
-123
-3% -$24.7K 0.55% 55
2020
Q4
$710K Buy
+4,058
New +$701K 0.52% 60

Other funds holding LH

Seelaus Asset Management's LH Position: Q1 2024 in Review

Seelaus Asset Management sold out of Labcorp (LH) in Q1 2024, closing a stake of 1,847 shares — an estimated $420K sold.

Seelaus Asset Management first reported a position in LH in Q4 2020 and held it in 9 quarters. The position peaked at $1.13M in Q2 2023. 927 funds tracked by Wall St. Rank hold LH as of Q1 2024.

  • Seelaus Asset Management reported no remaining Labcorp position as of Q1 2024 after selling out during the quarter.
  • Seelaus Asset Management sold 1,847 Labcorp shares in Q1 2024, an estimated $420K.
  • Seelaus Asset Management first reported a position in Labcorp in Q4 2020 and held it in 9 quarters.
  • Seelaus Asset Management's Labcorp position peaked at $1.13M in Q2 2023.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q1 2024.

Based on Seelaus Asset Management's 13F filing for Q1 2024, filed 1 May 2024.